SCHEMBL6694288

SCHEMBL6694288

O=C(NCc1ccc(F)cc1)c1ccc2c(c1)ncn2-c1n[nH]c2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.51
TDP1 Q9NUW8 1/20 0.51
MAPK10 P53779 2/20 0.49
MAPK8 P45983 1/20 0.49
IDO1 P14902 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
MAPK1 P28482 2/20 0.45
MAPK3 P27361 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ITK Q08881 1/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 3/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.43
CNR1 P21554 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6702887 0.91 MAPK1 (0.49) TP53TDP1IDO1MAPK1MAPK3
SCHEMBL6699272 0.91 TP53 (0.51) TP53TDP1MAPK10MAPK8IDO1
SCHEMBL6703136 0.90 TP53 (0.47) TP53TDP1IDO1SMN1; SMN2MAPK1
SCHEMBL6694919 0.88 TP53 (0.53) TP53TDP1MAPK1MAPK3NPC1
SCHEMBL6664702 0.85 TP53 (0.54) TP53TDP1IDO1SMN1; SMN2MAPT
SCHEMBL6664832 0.84 TP53 (0.54) TP53TDP1MAPK1MAPTHPGD
SCHEMBL6702873 0.84 TP53 (0.47) TP53TDP1MAPK10MAPK8IDO1
SCHEMBL6705339 0.84 TP53 (0.44) TP53TDP1SMN1; SMN2MAPK1HPGD
SCHEMBL6700631 0.83 ALDH1A1 (0.46) TP53TDP1SMN1; SMN2MAPK1MAPK3
SCHEMBL6703840 0.82 TP53 (0.53) TP53TDP1MAPK10MAPK8MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1441725-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS Aventis Pharmaceuticals Inc. (US) 2004-08-04 EP claimed
WO-2003035065-A1 BENZIMIDAZOLES AND ANALOGUES AND THEIR USE AS PROTEIN KINASES INHIBITORS AVENTIS PHARMACEUTICALS INC (US) 2003-05-01 WO claimed